Animal models have proven to be insufficient for predicting human response to cancer drugs. Xsphera overcomes these limitations with a human tissue-based platform that accurately captures the dynamic response of the tumor microenvironment across the diversity of patients.
We confront a critical issue in oncology drug development: the overwhelming majority of new drugs fail to obtain regulatory approval. This creates immense stress for the medical community and obstructs the evaluation of other promising treatments. As a consequence, billions of dollars are wasted, and patients are left with limited options for care.